Director DiMartino Rose purchases 1,000 shares of HQH at $18.88; stock up 9.0% in 30 days.
DiMartino Rose, a director of abrdn Healthcare Investors, acquired 1,000 shares at $18.88 on 2024-07-16, establishing an initial position in the fund. The purchase occurred near the 52-week high of $18.86, with the stock trading up 9.0% over the prior 30 days and 16.4% over 90 days, suggesting recent momentum in the asset class. This marks the director's fourth open-market buy across his cross-ticker track record, though this appears to be his first position in HQH specifically. The timing and context merit observation of whether the director's conviction persists through future filings.